High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran

Saudi Journal of Gastroenterology

Volumn 17, Issue 6, 2011, Pages 396-399

  Abadi, Amin ^a   Taghvaei, Tarang ^b   Ghasemzadeh, Ali ^c   Mobarez, Ashraf ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MARQUETTE UNIVERSITY   (United States)

Author keywords

Clarithromycin; Helicobacter pylori; Iran

Indexed keywords

ADENINE; CLARITHROMYCIN; GUANINE; RNA 23S;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DYSPEPSIA; FEMALE; HELICOBACTER PYLORI; HUMAN; IRAN; MALE; NONHUMAN; POINT MUTATION; RNA GENE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DYSPEPSIA; FEMALE; GENE FREQUENCY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RETROSPECTIVE STUDIES; RNA, BACTERIAL; YOUNG ADULT;

EID: 81255140887     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.87181     Document Type: Article

References (30)

1. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006;19:449-90. (Pubitemid 44134306)
2. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995;7:427-33.
3. Mansour-Ghanaei F, Yousefi Mashhour M, Joukar F, Sedigh M, Bagher- Zadeh AH, Jafarshad R. Prevalence of Helicobacter pylori infection among children in Rasht, Northern Iran. Middle East J Dig Dis 2009;1:84-8.
4. Megraud, F. H. pylori antibiotic resistance: Prevalence, importance, and advances in testing. Gut 2004;53:1374-84. (Pubitemid 39120130)
5. Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007;20:280-322. (Pubitemid 46709306)
6. O'Connor A, Gisbert JP, McNamara D, O'Morain C. Treatment of Helicobacter pylori Infection 2010. Helicobacter 2010;15 Suppl 1:46-52.
7. Alarcon T, Domingo D, Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents 1999;12:19-26. (Pubitemid 29241820)
8. Stone GG, Shortridge D, Flamm RK, Versalovic J, Beyer J, Idler K, et al. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1996;1:227-8. (Pubitemid 126671165)
9. Haghi Tomatari F, Mohabbati Mobarez A, Amini M, Hosseini D, Talebi Bezmin Abadi A. Helicobacter pylori resistance to metronidazole and clarithromycin in dyspeptic patients in Iran. IRCMJ 2010;12:409-12.
10. Boyanova L, Nikolov R, Lazarova E, Gergova G, Katsarov N, Kamburov V, et al. Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years. J Med Microbiol 2006;55:65-8. (Pubitemid 43031240)
11. Agudo S, Peerez-Perez G, Alarcon T, Lopez-Brea M. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain. J Clin Microbiol 2010;48:3703-7.
12. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; fifteenth information supplement. Wayne, PA, USA; 2007.
13. Ge Z, Taylor DE. Rapid PCR screening of Helicobacter pylori chromosomal point mutations. Helicobacter 1997;2:127-31. (Pubitemid 127686133)
14. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997;41:2621-8. (Pubitemid 27524731)
15. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40:477-80. (Pubitemid 26049364)
16. Sevin E, Lamarque D, Delchier JC, Soussy CJ, Tankovic J. Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. FEMS Microbiol Lett 1998;165:369-72. (Pubitemid 29090320)
17. Miehlke S, Yu J, Schuppler M, Frings C, Kirsch C, Negraszus N, et al. Helicobacter pylori vacA, iceA and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am J Gastroentrol 2001;96:1008-13. (Pubitemid 32319129)
18. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicenter survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001;20:820-3. (Pubitemid 34020461)
19. Van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, de Boer W, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998;115:58-66. (Pubitemid 28307288)
20. Simsek H, Balaban YH, Gunes DD, Hascelik G, Ozarslan E, Tatar G. Alarming clarithromycin resistance of Helicobacter pylori in Turkish population. Helicobacter 2005;10:360-1. (Pubitemid 41104976)
21. Khan R, Nahar S, Sultana J, Ahmad MM, Rahman M. T2182C Mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother 2004;48:3567-9. (Pubitemid 39129362)
22. Mohammadi M, Doroud D, Mohajerani N, Massarrat S. Helicobacter pylori antibiotic resistance in Iran. World J Gastroenterol 2005;11:6009-13. (Pubitemid 41749217)
23. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003;17:99-109. (Pubitemid 36140439)
24. Khashei R, Shojaei H, Adibi P, Shavakhi A, Aslani MM, Naser AD. Genetic diversity and drug resistance of Helicobacter pylori strains in Isfahan, Iran. Iran J Basic Med Sci 2008;11:174-82.
25. Siavoshi F, Pourkhajeh AH, Merat S, Asl-Soleimani H, Heidarian E, Khatibian M, et al. Susceptibility of various strains of Helicobacter pylori to selected agents. Arch Iran Med 2000;3:60-3.
26. Falsafi T, Mobasheri F, Nariman F, Najafi M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol 2004;42:387-9. (Pubitemid 38082753)
27. Bakir Ozbey S, Ozakin C, Keskin M. Antibiotic resistance rates of Helicobacter pylori isolates and the comparison of E-test and fluorescent in situ hybridization methods for the detection of clarithromycin resistant strains. Mikrobiyol Bul 2009;43:227-34.
28. Kalach N, Serhal L, Asmar E, Campeotto F, Bergeret M, Dehecq E, et al. Helicobacter pylori primary resistant strains over 11 years in French children. Diagn Microbiol Infect Dis 2007;59:217-22. (Pubitemid 47484134)
29. De Francesco V, Margiotta M, Zullo A, Hassan C, Giorgio F, Burattini O, et al. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J Antimicrob Chemother 2007;59:783-5. (Pubitemid 47073419)
30. De Francesco V, Margiotta M, Zullo A, Hassan C, Troiani L, Burattini O, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006;144:94-100. (Pubitemid 46768227)